Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial
Boadie W. Dunlop, Sagar V. Parikh, Anthony J. Rothschild, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial
Arun K. Tiwari, Clement C. Zai, C. Anthony Altar, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis
Mary Bunka, Gavin Wong, Daniel Kim, et al.
Psychiatry Research (2023) Vol. 321, pp. 115102-115102
Open Access | Times Cited: 19
Exploring the Impact of Flavonoids on Symptoms of Depression: A Systematic Review and Meta-Analysis
Sawan Alì, Graziamaria Corbi, Michaël Maes, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1644-1644
Open Access | Times Cited: 36
Noninvasive modulation of subcallosal cingulate and depression with focused ultrasonic waves
Thomas Riis, Daniel Feldman, Sarah Kwon, et al.
Biological Psychiatry (2024)
Closed Access | Times Cited: 4
Durability of clinical benefit with Stanford Neuromodulation Therapy (SNT) in treatment-resistant depression
Andrew Geoly, Katy H. Stimpson, Flint M. Espil, et al.
Brain stimulation (2025)
Open Access
Perinatal depression: Heterogeneity of disease and in animal models
Wansu Qiu, Travis E. Hodges, Emily L. Clark, et al.
Frontiers in Neuroendocrinology (2020) Vol. 59, pp. 100854-100854
Closed Access | Times Cited: 25
Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
Vibeke H. Dam, Dea Siggaard Stenbæk, Kristin Köhler‐Forsberg, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Clinical validation of the self-reported 6-item Hamilton Depression Rating Scale (HAM-D6-SR) among inpatients
Pernille Kølbæk, Cathrine Wildenschild Nielsen, Chanette Winther Buus, et al.
Journal of Affective Disorders (2024) Vol. 354, pp. 765-772
Open Access | Times Cited: 2
The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis
Aya Mamdouh Fayoud, Hisham Ahmed Orebi, Iman Abdelhady Elshnoudy, et al.
Psychopharmacology (2024) Vol. 241, Iss. 7, pp. 1299-1317
Open Access | Times Cited: 2
A Chinese adaptation of six items, self-report Hamilton Depression Scale: Factor structure and psychometric properties
Xuemei Wang, Haiyan Ma, Jing Zhong, et al.
Asian Journal of Psychiatry (2022) Vol. 73, pp. 103104-103104
Closed Access | Times Cited: 12
Sexual function improves as depressive symptoms decrease during treatment with escitalopram: results of a naturalistic study of patients with major depressive disorder
Sophia Weber, Vibe G. Frøkjær, Sophia Armand, et al.
The Journal of Sexual Medicine (2023) Vol. 20, Iss. 2, pp. 161-169
Closed Access | Times Cited: 6
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
Mark A. Frye, Charles B. Nemeroff
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 282-284
Open Access | Times Cited: 6
Alterations of the gut microbiota in borderline personality disorder
Hannah Rössler, Vera Flasbeck, Sören Gatermann, et al.
Journal of Psychosomatic Research (2022) Vol. 158, pp. 110942-110942
Closed Access | Times Cited: 9
Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
Vincent Beliveau, Ella Hedeboe, Patrick M. Fisher, et al.
NeuroImage Clinical (2022) Vol. 36, pp. 103224-103224
Open Access | Times Cited: 9
Performance and Psychometric Properties of Novel Brief Assessments for Depression in Children and Adolescents
Paul E. Croarkin, Paul A. Nakonezny, David W. Morris, et al.
JAACAP Open (2024)
Open Access | Times Cited: 1
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.

PubMed (2021) Vol. 21, Iss. 13, pp. 1-214
Closed Access | Times Cited: 10
Precision Medicine—A Demand Signal for Genomics Education
Bruce Doll, Mauricio De Castro, Melissa H. Fries, et al.
Military Medicine (2021) Vol. 187, Iss. Supplement_1, pp. 40-46
Open Access | Times Cited: 7
The influence of family therapy on psychological stress and social adaptability of depressed patients
Qinghua Chen, Wenqing Zhao, LI Qun, et al.
Work (2021) Vol. 69, Iss. 2, pp. 613-624
Closed Access | Times Cited: 6
Pharmacogenomics and Precision Psychiatry
Pratyusha Attaluri, Ayeshah G. Mohiuddin, Kowsar Teymouri, et al.
Springer eBooks (2024), pp. 3999-4015
Closed Access
Weekly transcranial magnetic stimulation (TMS) maintenance: a case series
Marzena Rybak, Gregory M. Peterson, Saxby Pridmore, et al.
The World Journal of Biological Psychiatry (2024), pp. 1-4
Open Access
Comparing the associations of three psychometric scales at baseline with long‐term prognosis of depression over a 10‐year period
Ching‐I Hung, Chia‐Yih Liu, Shih‐Chieh Hsu, et al.
International Journal of Methods in Psychiatric Research (2021) Vol. 31, Iss. 1
Open Access | Times Cited: 3
A Way to Increase the Sensitivity and Specificity of the Hamilton Depression and Anxiety Scales
Mehmet Güven Günver, Mustafa Şenocak, Reyhan İlhan, et al.
Psychiatry and Clinical Psychopharmacology (2021) Vol. 31, Iss. 3, pp. 292-302
Open Access | Times Cited: 2
Pharmacogenomics and antidepressants: efficacy and adverse drug reactions
Joseph F. Goldberg, Charles B. Nemeroff
Elsevier eBooks (2022), pp. 189-202
Closed Access | Times Cited: 1
Pharmacogenomics and Precision Psychiatry
Pratyusha Attaluri, Ayeshah G. Mohiuddin, Kowsar Teymouri, et al.
Springer eBooks (2023), pp. 1-17
Closed Access
The HAM-D6 through the lens of grief: Clinical considerations for administering the six-item Hamilton Depression Rating Scale in the context of bereavement
M. Goldman, Stephanie Napolitano, Kailey E. Roberts, et al.
Palliative & Supportive Care (2023) Vol. 21, Iss. 6, pp. 1079-1084
Closed Access
Page 1 - Next Page

Scroll to top